International Journal of Molecular Sciences (Jun 2021)

Role of Multiple Comorbidities and Therapies in Conditioning the Clinical Severity of DRESS: A Mono-Center Retrospective Study of 25 Cases

  • Andrea Toniato,
  • Chiara Gamba,
  • Jan Walter Schroeder,
  • Valeria Fabbri,
  • Scarlett Valeria Bernal Ortiz,
  • Linda Borgonovo,
  • Marta Piantanida,
  • Joseph Scibilia,
  • Luca Balossi,
  • Eleonora Brusamolino,
  • Emanuela Bonoldi,
  • Valentina Caputo,
  • Michele Nichelatti,
  • Elide Anna Pastorello

DOI
https://doi.org/10.3390/ijms22137072
Journal volume & issue
Vol. 22, no. 13
p. 7072

Abstract

Read online

DRESS/DiHS is a complex and potentially fatal drug reaction. Little is known about risk factors and elements that can help to identify patients with a severe reaction early. The aim of the study was to investigate those factors favoring the disease and its severity by analyzing the clinical conditions and therapies preceding the reaction. We conducted a retrospective analysis on patients admitted to our center between 2010 and 2020 who were discharged with a diagnosis of DRESS. We used the RegiSCAR diagnostic criteria. We defined the severity of DRESS using the criteria of Mizukawa et al. We included 25 patients (15 females) with a median age of 66 years. Skin involvement, eosinophilia, and liver injury were the most important aspects. Allopurinol was found to be the most involved drug. Reaction severity was significantly associated with the number of daily medications (p = 0.0067) and an age of at least 68 years (p = 0.013). In addition, 75% of severe cases had at least three comorbidities in history, and most of the severe cases were female. In our study the advanced age, the high number of comorbidities and home therapies, and the inflammatory state were found to be predisposing elements to the development of the disease and its severity.

Keywords